Siemens Healthineers AG (SHL.DE) Stock
Siemens Healthineers AG

Company profile
Siemens Healthineers reported revenue of 23.63 billion EUR for fiscal year 2026, and net income of 2.21 billion EUR. That is a net profit margin of 9.4% for fiscal year 2026. Its largest business segment, Imaging, brought in 56% of segment revenue in fiscal year 2025; United States was the largest region with 39%. Our analysis of its filings shows revenue growing from 22.36 billion EUR in fiscal year 2024 to 23.63 billion EUR in fiscal year 2026, 2.8% a year on average. Siemens Healthineers reports about 74,600 full-time employees.
Figures from company filings; latest fiscal year ended September 30, 2026.
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. It has strategic partnership with IFS and Novo. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.
Largest shareholders
- Siemens AG67.02%
- Siemens Healthineers AG0.99%
- Towers Watson Investment Management Ltd.0.08%
- Goldman Sachs Asset Management BV0.06%
- Evenlode Investment Management Ltd.0.05%
Share of the company, as of September 25, 2026
Leadership
- Bernhard Montag Ph.D. — President, CEO & Chairman of Management Board, 56
- Jochen Schmitz Ph.D. — CFO & Member of Management Board, 59
- Elaine Becraft — Chief Human Resources Officer
- Christian Klaussner — Executive Vice President of Finance
- Darleen Caron — Member of Management Board, 61
How much revenue does Siemens Healthineers make?
Siemens Healthineers reported 23.63 billion EUR in revenue for fiscal year 2026.
What is Siemens Healthineers's largest business segment?
Imaging, with 13.18 billion EUR or 56% of segment revenue in fiscal year 2025. Next: Diagnostics (18%) and Varian (17%).
Where does Siemens Healthineers make most of its revenue?
United States: 39% of revenue by region in fiscal year 2025, followed by Europe, Commonwealth of Independent States, Africa, Middle East (26%).
Company Information
Data as of .
How to cite: DataPorium, “Siemens Healthineers AG (SHL.DE)”, data as of Sep 30, 2026, https://dataporium.tech/stocks/SHL.DE